Filing Details
Prime Medicine, Inc. (NASDAQ:PRME) filed a Form 8-K with the Securities and Exchange Commission on July 08, 2026, disclosing a material event.
8k filedNASDAQ:PRME
Prime Medicine, Inc. (PRME) Reports Material Event to SEC
Filing Details Prime Medicine, Inc. (NASDAQ:PRME) filed a Form 8-K with the Securities and Exchange Commission on July 08, 2026, disclosing a material event. Market Context Prime…
Market Context
Prime Medicine, Inc.'s stock currently trades at $4.62 with a market capitalization of $754.0M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for Prime Medicine, Inc.'s stock.
All SEC filings for Prime Medicine, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View PRME Stock Page
Frequently Asked Questions
Where can I read PRME's SEC filings?
Browse all filings on our PRME SEC filings page.
What types of SEC filings does Prime Medicine, Inc. file?
Public companies like Prime Medicine, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.